Cargando…
Epidrugs: Toward Understanding and Treating Diverse Diseases
Epigenomic modifications are unique in the type and amount of chemical modification at each chromosomal location, can vary from cell to cell, and can be externally modulated by small molecules. In recent years, genome-wide epigenomic modifications have been revealed, and rapid progress has been made...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326711/ https://www.ncbi.nlm.nih.gov/pubmed/35893014 http://dx.doi.org/10.3390/epigenomes6030018 |
| _version_ | 1784757352019263488 |
|---|---|
| author | Umehara, Takashi |
| author_facet | Umehara, Takashi |
| author_sort | Umehara, Takashi |
| collection | PubMed |
| description | Epigenomic modifications are unique in the type and amount of chemical modification at each chromosomal location, can vary from cell to cell, and can be externally modulated by small molecules. In recent years, genome-wide epigenomic modifications have been revealed, and rapid progress has been made in the identification of proteins responsible for epigenomic modifications and in the development of compounds that regulate them. This Special Issue on “Epidrugs: Toward Understanding and Treating Diverse Diseases” aims to provide insights into various aspects of the biology and development of epigenome-regulating compounds. |
| format | Online Article Text |
| id | pubmed-9326711 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93267112022-07-28 Epidrugs: Toward Understanding and Treating Diverse Diseases Umehara, Takashi Epigenomes Editorial Epigenomic modifications are unique in the type and amount of chemical modification at each chromosomal location, can vary from cell to cell, and can be externally modulated by small molecules. In recent years, genome-wide epigenomic modifications have been revealed, and rapid progress has been made in the identification of proteins responsible for epigenomic modifications and in the development of compounds that regulate them. This Special Issue on “Epidrugs: Toward Understanding and Treating Diverse Diseases” aims to provide insights into various aspects of the biology and development of epigenome-regulating compounds. MDPI 2022-07-12 /pmc/articles/PMC9326711/ /pubmed/35893014 http://dx.doi.org/10.3390/epigenomes6030018 Text en © 2022 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Editorial Umehara, Takashi Epidrugs: Toward Understanding and Treating Diverse Diseases |
| title | Epidrugs: Toward Understanding and Treating Diverse Diseases |
| title_full | Epidrugs: Toward Understanding and Treating Diverse Diseases |
| title_fullStr | Epidrugs: Toward Understanding and Treating Diverse Diseases |
| title_full_unstemmed | Epidrugs: Toward Understanding and Treating Diverse Diseases |
| title_short | Epidrugs: Toward Understanding and Treating Diverse Diseases |
| title_sort | epidrugs: toward understanding and treating diverse diseases |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326711/ https://www.ncbi.nlm.nih.gov/pubmed/35893014 http://dx.doi.org/10.3390/epigenomes6030018 |
| work_keys_str_mv | AT umeharatakashi epidrugstowardunderstandingandtreatingdiversediseases |